Antibody Response to Immunization with Purified GD3 Ganglioside and GD3 Derivatives (Lactones, Amide and Gangliosidol) in the Mouse

LIVINGSTON, 1987, Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patients, Proc. Natl. Acad. Sci. USA., 84, 2911, 10.1073/pnas.84.9.2911 TAI, 1985, Immunogenicity of melanoma-associated gangliosides in cancer patients, Int. J. Cancer, 35, 607, 10.1002/ijc.2910350507 LIVINGSTON, 1985, IV. Serological response in stage II melanoma patients receiving allogeneic melanoma cell vaccines, Cancer, 56, 2194, 10.1002/1097-0142(19851101)56:9<2194::AID-CNCR2820560910>3.0.CO;2-L TSUCHIDA, 1987, Gangliosides of human melanoma: altered expression in vivo and in vitro, Cancer Res., 47, 1278 WELT, 1987, Immune and nonimmune effector functions of IgG3 mouse mAb R24 detecting the disialoganglioside GD3 on the surface of melanoma cells, Clin. Immunol. Immunopath., 45, 214, 10.1016/0090-1229(87)90036-5 CARUBIA, 1984, Gangliosides of normal and neoplastic melanocytes, Biochem. Biophys. Res. Comm., 120, 500, 10.1016/0006-291X(84)91282-8 HOUGHTON, 1985, Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase I trial in patients with malignant melanoma, Proc. Natl. Acad. Sci. USA., 82, 1242, 10.1073/pnas.82.4.1242 CAHAN, 1982, Identification of a human neuroectodermal tumor antigen (OFA-I-2) as ganglioside GD2, Proc. Natl. Acad. Sci. USA., 79, 7629, 10.1073/pnas.79.24.7629 Momoi, 1980, Separation and micro-detection of oligosaccharides of GSL by HP-cellulose thin-layer chromatography-autoradiofluorography, HoppeSeyler's Z. Physiol. Chem., 361, 1209, 10.1515/bchm2.1980.361.2.1201 RITTER, 1990, Biochemical and serological characteristics of natural 9-0-acetyl GD3 from human melanoma, bovine buttermilk and chemically O-acetylated GD3, Cancer Res., 50, 1403 ANDO, 1989, High resolution proton NMR studies of gangliosides. Structure of two types of GD3 lactones and their reactivity with mAb R24, J. Biol. Chem., 264, 3478, 10.1016/S0021-9258(18)94091-3 IWAMORI, 1978, A new approach to the resolution of individual gangliosides by ganglioside mapping, Biochim. Biophys. Acta, 528, 257, 10.1016/0005-2760(78)90200-X SONNINO, 1983, Recognition by two-dimensional TLC and densitometric quantification of alkali-labile gangliosides from the brain of different animals, Anal. Biochem., 128, 104, 10.1016/0003-2697(83)90350-0 NORES, 1987, Density-dependent recognition of cell surface GM3 by a certain anti-melanoma antibody, and GM3 lactone as a possible immunogen, J. Immunol., 139, 3171 DIPPOLD, 1980, Cell surface antigens of human malignant melanoma: definition of six antigenic systems with monoclonal antibodies, Proc. Natl. Acad. Sci. USA., 77, 6114, 10.1073/pnas.77.10.6114 LIVINGSTON, 1983, Comparism of approaches for augmenting the serolog. response to the individually spec. methylcholanthrene-induced sarcoma-Meth A, J. Immunol., 131, 2601, 10.4049/jimmunol.131.5.2601 LIVINGSTON, 1987, Approaches to augmenting the immunogenicity of the ganglioside GM2 in mice. Purified GM2 is superior to whole cells, J. Immunol., 138, 1524, 10.4049/jimmunol.138.5.1524 MAGNANI, 1980, Detection of gangliosides that bind cholera toxin: direct binding of 1251-labeled toxin to thin-layer chromatograms, Anal. Biochem., 109, 399, 10.1016/0003-2697(80)90667-3 RITTER, 1987, Glycosphingolipid composition of human semen, Arch. Biochem. Biophys., 257, 370, 10.1016/0003-9861(87)90579-0 SHIKU, 1976, Cell surface antigens of human malignant melanoma, J. Exp. Med., 144, 873, 10.1084/jem.144.4.873 PFREUNDSCHUH, 1978, Serological analysis of cell surface antigens of malignant human brain tumors, Proc. Natl. Acad. Sci. USA., 75, 5122, 10.1073/pnas.75.10.5122 MACDONALD, 1980, Notes on improved procedures for the chemical modification and degradation of glycosphingolipids, J. Lipid Res., 21, 642, 10.1016/S0022-2275(20)42235-7 RITTER, 1989, Development of melanoma vaccines: Gangliosides as immunogens, 301 LIVINGSTON, 1989, Antibody response after immunization with the gangliosides GM 1, GM2, GM3, GD2 and GD3 in the mouse, Cancer Immunol. Immunother., 29, 179, 10.1007/BF00199993 LIVINGSTON, 1989, Immunization of melanoma patients with purified gangliosides, 293 NAKAMURA, 1986, Biochemical properties of N-methyl-amides of sialic acids in gangliosides, J. Biochem., 99, 219, 10.1093/oxfordjournals.jbchem.a135462 HANDA, 1984, Modification of sialic acid carboxyl group of gangliosides, J. Biochem., 95, 1323, 10.1093/oxfordjournals.jbchem.a134738 DOHI, 1988, An IgG3 mAb established after immunization with GM3 lactone: Immunochemical specificity and inhibition of melanoma cell growth, Cancer Res., 48, 5680 KLEIN, 1987, Metabolism of ganglioside-amides in cultured human fibroblasts, Biol. Chem. Hoppe' Seyler, 368, 1496, 10.1515/bchm3.1987.368.2.1495 LI, 1984, Effect of modification of sialic acid on enzymatic hydrolysis of gangliosides GM1 and GM2, J. Biol. Chem., 259, 5409, 10.1016/S0021-9258(18)91025-2 GILLARD, 1989, Antibodies against ganglioside GT3 in the sera of patients with type I diabetes mellitus, J. Immunol., 142, 3826, 10.4049/jimmunol.142.11.3826 YU, 1985, High-resolution proton NMR studies of gangliosides. III. Elucidation of the structure of GM3 lactone, J. Biochem., 98, 1367, 10.1093/oxfordjournals.jbchem.a135404 SVENNERHOLM, 1963, Chromatographic separation of human brain gangliosides, J. Neurochem., 10, 613, 10.1111/j.1471-4159.1963.tb08933.x